Ironwood Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Almirall EUR 353.42M 79.41M 2024-12
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 201.55M 28.99M 2024-09
Ardelyx USD 77.83M 7.33M 2024-12
Astellas Pharma JPY 1.06T 90.95B 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Charles River Laboratories USD 1.05B 56.95M 2025-03
Exact Sciences USD 502.46M 229.72M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Incyte USD 1.89B 244.96M 2025-03
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
MacroGenics USD 55.53M 3.78M 2024-12
Moderna USD 1.6B 602M 2025-03
Myriad Genetics USD 151.1M 13M 2025-03
Pacira USD 314.73M 4.81M 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Takeda JPY 2.51T 408.56B 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12



Ironwood Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.